Official data from INPI

122022020165

Em AnáliseUtility ModelPCT · JP2018032104

Talk to an expert

Application data

Number

122022020165

Type

Utility Model

Filing

08/30/2018

Publication

PCT

JP2018032104

View on INPI

Progress at the INPI

Technical opinion to answer

Filing08/30/18
Publication
Examination
Allowance
Grant
In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Latest action published by the INPI: 05/26/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

OTSUKA PHARMACEUTICAL CO., LTD.

See this company's full portfolio

Inventors

No inventors listed.

Technical data

IPC Classification

No IPC classification.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Conhecimento de parecer técnico

#7.1

05/26/2026

RPI 2890

Notificação de pedido dividido

#2.4

11/16/2022

RPI 2706

Requerimento de pedido de patente

#2.10

Número de Protocolo '870220091385' em 05/10/2022 16:48 (WB)

10/18/2022

RPI 2702

From the same holder

112026018128 112026006203 INIBIDOR DE DIFERENCIAÇÃO E MATURAÇÃO DE MEGACARIÓCITOS 112025023808 112025017804 INICIAÇÃO DE DOSE PARA O TRATAMENTO DE ESQUIZOFRENIA OU TRANSTORNO BIPOLAR TIPO I COM ARIPIPRAZOL 112025022101 MÉTODOS DE DISPERSÃO DE PREPARAÇÕES INJETÁVEIS DE ARIPIPRAZOL

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.